Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
05. Januar 2022 08:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Added to the Nasdaq Biotechnology Index
14. Dezember 2021 08:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Establishment of New Charitable Foundation
09. Dezember 2021 16:00 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022
10. November 2021 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces November 2021 Investor Conference Schedule
02. November 2021 08:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
13. Oktober 2021 16:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans...
Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
07. Oktober 2021 05:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today...
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
04. Oktober 2021 08:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research,...
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
10. September 2021 06:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
07. September 2021 16:10 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...